Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response…
NCT00165776 · Eisai Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00165776 |
|---|---|
| Title | Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis |
| Lead sponsor | Eisai Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Dystonia, Spasmodic Torticollis |
| Intervention type | Drug |
| Interventions | BOTULINUM TOXIN TYPE B |
| Enrollment | 133 |
| Start date | Jun 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 10, 2014 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: